| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.0088 |
0.9 |
| mRNA |
3-Cl-AHPC |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.0068 |
0.9 |
| mRNA |
WH-4-023 |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
-0.0078 |
0.9 |
| mRNA |
LY-2157299 |
CTRPv2 |
pan-cancer |
AAC |
0.01 |
0.9 |
| mRNA |
lenalidomide |
GDSC1000 |
pan-cancer |
AAC |
0.0052 |
0.9 |
| mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.0048 |
0.9 |